BSE filing, NSE: BPLPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Bharat Parenterals Ltd: key numbers
- Share price
- ₹2,026.65
- Market cap
- ₹1,397 Cr
- Revenue (annual)
- ₹345.4 Cr
- Net profit (annual)
- ₹-8.19 Cr
- P/E (TTM)
- 1123.0×Sector 45.9×
- Promoter holding
- 67.20%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bharat Parenterals Ltd
All →Bharat Parenterals Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹136.3 Cr (+110.9% YoY), EBITDA ₹23.6 Cr (17.3%), PAT ₹11.8 Cr; Innoxel turned profitable.
Bharat Parenterals Q2 FY27 Results: Turns Profitable, Net Profit ₹11.8 Cr
Bharat Parenterals approved unaudited standalone results for the quarter ended 30 September 2026. The company reported profit and revenue growth versus the prior-year quarter.
- Key figure
- Net profit ₹11.8 Cr
Bharat Parenterals Board Meeting Date
Bharat Parenterals will hold a board meeting on October 29, 2026 to consider unaudited standalone and consolidated results. Trading window has been closed since October 1, 2026.
Bharat Parenterals Annual General Meeting
Bharat Parenterals held an EGM via video conferencing on October 23, 2026. Members considered a preferential equity issue and Section 186 investment and guarantee limits.
Bharat Parenterals Business Update
Innoxel Lifesciences, a Bharat Parenterals subsidiary, began U.S. commercial supply of its first CMO product. This adds recurring manufacturing revenue to its existing licensing income.
Bharat Parenterals Preferential Issue
Bharat Parenterals filed a corrigendum to its EGM notice for a preferential issue exceeding ₹100 Crore. It adds a Crisil monitoring agency disclosure per BSE direction.
Other price movement clarification announcements
All →Black Opal Consultants Price Movement Clarification
Black Opal Consultants clarified to BSE on recent share price movement. It says no pending price-sensitive information exists and the move appears market-driven.
SJP Ultrasonics Price Movement Clarification
SJP Ultrasonics clarified to BSE that it is unaware of any undisclosed price-sensitive information behind a recent significant share price movement. It cannot comment on the causes, which it attributes to market factors.
Filtron Engineers Price Movement Clarification
Filtron Engineers says its recent share price movement is market-driven and no price-sensitive information is pending. It replies to a BSE query dated 29 October 2026.
Century Business Media Price Movement Clarification
Century Business Media is unaware of any reason for its recent share price movement. It attributes the move to market conditions.
Suzlon Energy Price Movement Clarification
Suzlon Energy reported a material price movement on 30 Oct 2026. The company stated no identifiable event or media report triggered the move.
NMS Global Price Movement Clarification
NMS Global responded to BSE's October 27 price-movement query, stating it is unaware of any undisclosed material event. The price move appears market-driven.